Results 141 to 150 of about 9,431 (199)

Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. [PDF]

open access: yesMol Genet Metab
Kell P   +14 more
europepmc   +1 more source

Mapping Sanfilippo Syndrome: A Multisystem Clinicopathological Autopsy. [PDF]

open access: yesDiagnostics (Basel)
Trandafirescu MF   +9 more
europepmc   +1 more source

[Case of mucopolysaccharidosis II--Hunter's syndrome].

open access: yesPediatria polska, 1976
M, Walczak   +3 more
openaire   +1 more source

Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB. [PDF]

open access: yesJIMD Rep
Wijnen M   +5 more
europepmc   +1 more source

Newborn Screening and Early Cord Blood Transplant for Mucopolysaccharidosis.

open access: yesJAMA Netw Open
Sakaguchi H   +18 more
europepmc   +1 more source

Audiologic evaluations of children with mucopolysaccharidosis [PDF]

open access: yesBrazilian Journal of Otorhinolaryngology, 2016
INTRODUCTION: Mucopolysaccharidosis is a hereditary lysosomal storage disease, which develops due to a deficiency in the enzymes that play a role in the metabolism of glycosaminoglycans (GAG).
Håkan Tutar   +2 more
exaly   +2 more sources

Nasal Polyposis in mucopolysaccharidosis type II

BMJ Case Reports, 2021
Mucopolysaccharidosis (MPS) type II is a rare multisystem disorder resulting from the accumulation of breakdown products of glycosaminoglycans in the body tissues. Many patients with this disease undergo ENT (ear, nose and throat) surgeries such as adenotonsillectomy and tympanocentesis at a very early age, much before the diagnosis of MPS.
Sushmitha Kabekkodu   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy